4.65 DESTINY BREAST 04 - A complex trial to deconstruct
Plenary Session - inactive due to federal service - Un pódcast de Vinay Prasad, MD MPH
Categorías:
My take on the standing ovation for DESTINY Breast 04 Traztuzumab Deruxtecan vs. Investigator choice after endocrine therapy and 1 or 2 chemotherapies for HER2 low
